SCHEMBL31709710

SCHEMBL31709710

CCC1C(c2ccc(C(F)(F)F)cc2)=C(O)C(=O)N1CCCCN1C(=O)C(O)=C(c2ccc(C(F)(F)F)cc2)C1CC

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 1/20 0.35
KIF11 P52732 2/20 0.35
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 2/20 0.33
ANXA2 P07355 1/20 0.33
S100A10 P60903 1/20 0.33
CCR1 P32246 1/20 0.33
CCR2 P41597 1/20 0.33
BACE1 P56817 1/20 0.33
P2RX7 Q99572 1/20 0.32
HPGD P15428 1/20 0.32
CNR2 P34972 1/20 0.32
MEN1 O00255 1/20 0.32
HSP90AA1 P07900 1/20 0.32
MAPT P10636 1/20 0.32
CRHBP P24387 1/20 0.32
KMT2A Q03164 1/20 0.32
CRHR2 Q13324 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31709716 0.99 KDM4E (0.36) TLR8KIF11KDM4EALDH1A1ANXA2
SCHEMBL26134634 0.96 TLR8 (0.40) TLR8KIF11KDM4EALDH1A1CNR2
SCHEMBL26125847 0.95 KDM4E (0.41) TLR8KDM4EALDH1A1CNR2
SCHEMBL26124979 0.95 KDM4E (0.41) TLR8KDM4EALDH1A1CNR2
SCHEMBL31710487 0.95 KIF11 (0.37) KIF11KDM4EALDH1A1CCR1CCR2
SCHEMBL26135826 0.94 TLR8 (0.34) TLR8KIF11KDM4EALDH1A1ANXA2
SCHEMBL31710414 0.93 TLR8 (0.34) TLR8KIF11KDM4EALDH1A1ANXA2
SCHEMBL31709660 0.92 DRD2 (0.33) TLR8KIF11KDM4EALDH1A1ANXA2
SCHEMBL31709816 0.91 KIF11 (0.32) KIF11KDM4EALDH1A1ANXA2S100A10
SCHEMBL31710345 0.90 MAOB (0.35) TLR8KIF11ANXA2S100A10CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326718-A1 4-PHENYL-2-PYRROLIDINONES AND METHODS OF USING THEREOF UNIV NORTH CAROLINA STATE (US) 2025-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326718-A1 4-PHENYL-2-PYRROLIDINONES AND METHODS OF USING THEREOF PGLS, ALG8, PFAS TLR8 290/4885KIF11 4542/4885KDM4E 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.